Bill
Bill > A4628
NJ A4628
Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.
summary
Introduced
06/25/2024
06/25/2024
In Committee
06/25/2024
06/25/2024
Crossed Over
Passed
Dead
Introduced Session
2024-2025 Regular Session
Bill Summary
This bill requires health insurers (health, hospital, and medical service corporations, commercial individual and group health insurers, health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to provide coverage for expenses incurred in the purchase and use of a continuous glucose monitoring system, as prescribed by health care practitioner for the treatment of glycogen storage disease.
AI Summary
This bill requires health insurers (including hospital, medical, and health service corporations, individual and group health insurers, health maintenance organizations, and state and school employee health benefits programs) to provide coverage for the purchase and use of a continuous glucose monitoring system, as prescribed by a health care practitioner, for the treatment of glycogen storage disease. The benefits must be provided to the same extent as for any other medical condition under the respective health plans or contracts. The bill applies to all health benefits plans delivered, issued, executed, or renewed in New Jersey on or after the effective date.
Committee Categories
Business and Industry
Sponsors (3)
Last Action
Introduced, Referred to Assembly Financial Institutions and Insurance Committee (on 06/25/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.njleg.state.nj.us/bill-search/2024/A4628 |
| BillText | https://pub.njleg.gov/Bills/2024/A5000/4628_I1.HTM |
Loading...